A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.

Park DK, Ryan CW, Dolan ME, Vogelzang NJ, Stadler WM. A phase II trial of oral temozolomide in patients with metastatic renal cell cancer. Cancer Chemother Pharmacol. 2002 Aug; 50(2):160-2.

View in: PubMed

subject areas

Aged
Antineoplastic Agents, Alkylating
Carcinoma, Renal Cell
Dacarbazine
Drug Resistance, Neoplasm
Female
Humans
Kidney Neoplasms
Life Tables
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Proteins
O(6)-Methylguanine-DNA Methyltransferase
Salvage Therapy
Survival Analysis
Treatment Failure

authors with profiles

Walter M. Stadler
Mary Eileen Dolan